We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Export Driven Multidisciplinary Approach Wins EFF Manufacturing Award for 2011

By LabMedica International staff writers
Posted on 30 Nov 2011
Binding Site (Birmingham, UK), a developer and producer of laboratory based tests for the diagnosis and monitoring of blood cancers and immunodeficiency diseases, won the EEF (Engineering Employers Federation) Midlands Outstanding Export Award, sponsored by the UKTI (UK Trade and Investment). More...


Binding Site’s export strategy has been developed and refined for more than ten years to become integral to all aspects of the business. Initially, the export initiative was led by the sales and marketing team, but as overseas expansion gathered pace, the company drew on the support of technical, R&D, human resources, and finance departments. As a result of this multidisciplinary approach, Binding Site currently exports around 90% of its products – with the United States accounting for 47% of total sales.

The annual awards are hosted by EEF, the manufacturers’ organization, and recognize excellence in enterprise, innovation, environmental performance, and skills development among UK manufacturers. Richard Halstead, EEF Midlands Regional Director, said, “Manufacturing is crucial to our region’s economic recovery. Companies like Binding Site are leading the way by taking a research-led approach to developing niche export markets for high value, knowledge-based products. Congratulations to them on this well deserved success.”

Binding Site will go forward to compete against other regional winners from across the UK in EEF’s National Awards final, to take place on January 26, 2012, in London (UK).

Related Links:
Binding Site



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.